Medical Device Recall Statistics: 2026 Data

From January through April 2026, our research team analyzed FDA medical device recall databases, manufacturer safety reporting systems, and industry benchmark data covering 2020 through the present. This report compiles recall frequency trends, root cause breakdowns, manufacturer performance records, and financial impact data for healthcare procurement professionals assessing supply chain risk.

Medical device recalls reached 1,059 events in 2024, the highest total in four years. Class I recalls, the most serious category indicating reasonable probability of serious injury or death, hit a 15-year peak. Device failure overtook manufacturing defects as the leading cause for the first time in over five years. Early 2026 data confirms Class I events remain at historically elevated levels. The table below summarizes year-over-year recall trends across the full analysis period.

Medical Device Recall Volume by Year: 2020–2026

Between 2020 and 2024, the medical device industry experienced a sharp rise in Class I recalls and affected units, signaling growing operational and patient safety risks.

Year	Total Recall Events	Units Affected (Millions)	Class I Recalls	Class I as % of Total	YOY Change
2020	1,015	264.3	33	3.3%	Baseline
2021	871	198.7	41	4.7%	-14.2%
2022	960	245.8	55	5.7%	+10.2%
2023	975	283.4	68	7.0%	+1.6%
2024	1,059	440.4	114	10.8%	+8.6%
2025	1,143	583.7	145	11.4%	+9.1%
2026 (Proj.)	236 / 944	18.6 / 74.4	31 / 124	13.1%	-10.9% proj.

Key Insights:

• Class I recalls increased 245% from 2020 to 2024, rising from 33 events to 114 events in four years.
• Units affected surged 55.4% in 2024 alone, jumping from 283.4 million to 440.4 million, meaning each individual recall affected more devices on average.

Top Device Categories by Recall Frequency: 2024–2026

Life-sustaining devices account for the majority of Class I recall events across the analysis period. The table below ranks device categories by total recall volume and corresponding patient risk.

Device Category	Total Recalls	Units Affected	Class I Events	Procurement Risk
Ventilators	8	552,833	8	Critical
Infusion Pumps	7	45,377	7	Critical
Pacemakers	6	186,000	5	High
Tracheostomy Tubes	4	966,432	4	Critical
Syringe Pumps	4	12,800	4	High
Endoscopic Systems	3	290,000	3	Moderate
Resuscitators	3	39,084	3	Critical
Cardiac Monitoring	3	28,500	2	Moderate
IPV Therapy Equipment	2	94,000	2	Moderate
Insulin Pumps	2	8,900	2	High

Key Insights:

• Life-support devices dominate Class I recalls — ventilators, infusion pumps, and resuscitators collectively account for 18 of the top recall events.
• Tracheostomy tubes produced the largest single-product recall volume at 966,432 units, demonstrating how one material defect can affect nearly one million patients.

Top Manufacturers by Recall Events: 2024–2026

The table below ranks medical device manufacturers by total recall activity. Procurement teams use this data to benchmark supplier reliability and assess vendor risk before entering supply agreements.

Manufacturer	Total Recalls	Units Affected	Class I Recalls	Most Recalled Product	Primary Issue
Philips	8	552,833	7	Ventilators	Software / foam degradation
Smiths Medical	6	966,432	5	Tracheostomy tubes	Material defects
Medtronic	6	432,675	4	Cardiac monitoring	Component failure
Baxter Healthcare	6	61,377	5	Infusion systems	Software errors
GE HealthCare	4	118,400	3	Incubators / pumps	Hardware failure
Boston Scientific	3	96,000	3	Pacemakers	Battery / electrical
Getinge	3	290,000	3	Surgical systems	Design defect
Tandem Diabetes	3	8,200	3	Insulin pumps	Mobile app software
Fresenius Kabi	3	2,800	3	IV pumps	Dosing algorithm
Abiomed	2	14,600	2	Heart pumps	Software update

Key Insights:

• Philips leads in both total recalls and Class I events, with ongoing respiratory equipment safety issues extending from 2021 through 2026, pointing to systemic quality management challenges rather than isolated incidents.
• Smiths Medical recorded the highest unit impact of any manufacturer, with 966,432 devices affected in a single tracheostomy tube recall.

Root Causes of Medical Device Recalls: 2024

Device failure surpassed quality and manufacturing issues as the leading recall cause in 2024. Software defects grew at the fastest rate of any category, increasing 31% year-over-year as connected devices became more prevalent.

Cause Category	Recall Events	% of Total	Units Affected (Millions)	Trend vs. 2023	Avg. Resolution (Days)
Device Failure	118	11.1%	15.2	↑ 47%	145
Quality Issues	98	9.3%	22.8	↑ 12%	127
Software Defects	87	8.2%	8.9	↑ 31%	156
Mislabeling	76	7.2%	18.4	↓ 8%	98
Manufacturing Problems	73	6.9%	28.6	↑ 15%	134
Parts / Component Issues	69	6.5%	35.1	↑ 22%	142
Safety Concerns	64	6.0%	41.3	↑ 19%	167
Contamination	52	4.9%	12.7	↓ 5%	121
Design Flaws	47	4.4%	19.8	↑ 9%	189
Packaging Defects	39	3.7%	7.2	↓ 11%	87

Key Insights:

• Device failure became the top recall cause for the first time in over five years, reflecting the growing complexity of devices that now incorporate sensors, wireless connectivity, and embedded AI algorithms.
• Software defects grew 31% year-over-year and averaged 156 days to resolve, the second-longest average resolution time of any cause category.

Financial Impact of Medical Device Recalls: Per-Event Estimates

Recall costs extend far beyond immediate product retrieval. Business disruption accounts for the largest share of total recall expenses, and full recovery timelines commonly stretch two to five years.

Cost Category	Typical Range	% of Total Cost	Primary Cost Drivers	Recovery Timeline
Business Disruption	$15M – $200M	49%	Production halts, lost contracts, supply rerouting	12–24 months
Direct Recall Costs	$10M – $50M	35%	Product retrieval, replacement, and logistics	3–6 months
Legal / Litigation	$5M – $150M	8%	Class actions, settlements, defense	18–36 months
Brand / Reputation	$10M – $100M	5%	Market share loss, stock decline	24–60 months
Regulatory Penalties	$1M – $25M	3%	FDA fines, consent decrees	6–12 months
Total Per Major Recall	$41M – $525M	100%	—	2–5 years

Key Insights:

• Business disruption costs nearly match all other categories combined, representing 49% of total recall impact, and they arrive before any litigation or regulatory action begins.
• A single major Class I recall can cost a manufacturer up to $525 million when accounting for litigation, regulatory response, and long-term reputational damage.

About XS Supply

XS Supply is a Florida-based surgical supply distributor specializing in surplus OEM products. The company sources sealed, sterile surgical supplies directly from hospitals and manufacturers, then passes those savings to healthcare facilities at 20–40% below OEM pricing. Its regulatory compliance sets a gold standard in the industry, with cutting-edge anti-counterfeiting technology and FDA-connected inventory systems that give procurement teams full lot-level visibility.

XS Supply serves 500+ healthcare facilities across the United States with no contracts, no minimum orders, and same-day shipping available throughout Florida. For facilities managing recall risk, that combination of verified OEM quality, rapid fulfillment, and flexible purchasing terms removes a major operational vulnerability.

Request a PDF Copy of This Report

Contact XS Supply today to receive your comprehensive "Medical Device Recall Statistics: 2026 Report" in PDF format.

XS Supply only purchases from hospitals, surgical centers, and other vetted industry vendors. XS Supply does not purchase personal medical supplies from individuals.